Navigation Links
Pharmacopeia to Present at the 15TH Annual Future Leaders in the Biotech Industry Conference
Date:3/20/2008

wn internally-funded drug discovery programs, third party collaborations and in-licensing, Pharmacopeia's ability to raise additional capital, Pharmacopeia's expectations concerning the development priorities of its collaborators, their ability to successfully develop compounds and its receipt of milestones and royalties from the collaborations, Pharmacopeia's anticipated operating results, financial condition, liquidity and capital resources, Pharmacopeia's expectations concerning the legal protections afforded by U.S. and international patent law, Pharmacopeia's ability to pursue the development of new compounds and other business matters without infringing the patent rights of others, additional competition, and changes in economic conditions.

Further information about these and other relevant risks and uncertainties may be found in Pharmacopeia's Reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Pharmacopeia urges you to carefully review and consider the disclosures found in its filings which are available in the SEC EDGAR database at http://www.sec.gov and from Pharmacopeia at http://www.pharmacopeia.com. All forward-looking statements in this press release and oral statements made with respect to information contained in this press release are qualified entirely by the cautionary statements included in this press release and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by such forward-looking statements. These forward-looking statements speak only as of the date of this press release. Pharmacopeia undertakes no obligation to (and expressly disclaims any such obligation to) publicly update or revise the statements made herein or the risk factors that may relate thereto whether as a result of new information, future events, or otherwi
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
2. Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference
3. Pharmacopeia Announces Management Team Changes
4. Pharmacopeia To Present at BMO Capital Markets Seventh Annual Focus on Healthcare Conference
5. Pharmacopeia to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
7. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
8. Caliper Life Sciences to Present at Lehman Brothers Global Healthcare Conference
9. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
10. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
11. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The Board of Directors of BD ... declared a quarterly dividend of 54.5 cents per common share ... September 9, 2014. The indicated annual dividend rate is $2.18 ... is a leading medical technology company that partners with customers ... and evolving health needs. Our innovative solutions are focused on ...
(Date:7/22/2014)... within a phylum so full of mean little creatures, the ... its cruelty -- at least to crickets. Native to the ... most predatory sort of parasite. It swoops onto the back ... and leaves its wicked brood to invade, kill and consume ... would be possible without the fly,s ability to find a ...
(Date:7/22/2014)... Institute of Standards and Technology (NIST) and California ... design for an atomic clock that is based ... , The microcomb clock, featured on the cover ... Optica ,* is the first demonstration of ... conversion of optical frequencies to lower microwave frequencies. ...
(Date:7/22/2014)... in water with ultrasound and they,ll spin around their ... yet knows exactly. But researchers at the National Institute ... it,s fast. At up to 150,000 revolutions per minute, ... object submerged in liquid ever reported. , The discovery ... that they could be used not only for moving ...
Breaking Biology Technology:Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4'Comb on a chip' powers new NIST/Caltech atomic clock design 2NIST shows ultrasonically propelled nanorods spin dizzyingly fast 2
... the Albert Einstein College of Medicine of Yeshiva University ... can cure hemophilia A (the most common form of ... online February 14 in the Journal of Clinical Investigation. ... is characterized by recurrent, spontaneous bleeding that can cause ...
... at the University of Illinois helped lead a ... strategy for serious Staphylococcus aureus (Staph) infections. The ... version of Science magazine, comes at a time ... for methicillin-resistant S. aureus) are spreading in epidemic ...
... Hospital(R), the premier pediatric research and treatment center, can ... ... More than 60,000 callers,generated $6.1 million dollars during the ... a division of Univision,Communications Inc. The radiothon, benefiting St. Jude ...
Cached Biology Technology:Transplanted cells may hold the key to curing hemophilia A, Einstein scientists report 2New approach may render disease-causing staph harmless 2New approach may render disease-causing staph harmless 3More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 2More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases 3
(Date:7/22/2014)... exhibit consists of both still images and video ... scientific research. Forty-four still images were chosen from ... postdocs, staff, and alumni representing more than 25 ... more than 50 submissions. , Zach Donnell, a ... the 2014 organizers, noted that the exhibit highlights ...
(Date:7/22/2014)... Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2014. ... million, an increase of 53% compared to $4.4 million in ... income in the second quarter of 2014 was $1.4 million ... The increase in revenue and operating income was driven by ...
(Date:7/22/2014)... professor with an expertise in big data and bioinformatics ... more than $600,000 to develop an interactive database of ... associate professor, will lead the project with professor Chris ... Engineering department. Scientists are compiling and studying data related ... involved in fruit fly development are commonly found in ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7UT Arlington big data team wins $600,000 NSF grant to build gene expression database 2
... will host its largest ever annual meeting next week ... diagnostic professionals plus 1,300 representatives from more than 180 ... sessions and 350 poster presentations, the AMP 2013 Annual ... all things molecular. The event, to be held November ...
... membrane-crossing pores, using Lego-like DNA building blocks, has been developed ... University of Cambridge and the University of Southampton. ... synthetic biology and the technique has potential applications in diagnostic ... current issue of the journal Angewandte Chemie . ...
... Mass. (November 4, 2013) Whitehead Institute scientists report ... known as Birt-Hogg-Dub cancer syndrome also prevents activation of ... This is an unexpected finding, as ... their unchecked growth and expansion. In the case of ...
Cached Biology News:The Association for Molecular Pathology announces highlights of Phoenix meeting 2Designer piercings: New membrane pores with DNA nanotechnology 2Designer piercings: New membrane pores with DNA nanotechnology 3Gene responsible for hereditary cancer syndrome found to disrupt critical growth-regulating pathway 2
Denhardt's Solution is a mixture of blocking agents used in membrane-based hybridization protocols. The solution contains 1% Ficoll (type 400) 1% polyvinylpyrrolidone and 1% bovine serum albumin. Ste...
... 97 Cytological Labeling Kit provides a unique ... of cellular targets, including cell-surface receptors and ... Kit contains the patented ELF 97 phosphatase ... precipitate at the site of enzymatic activity ...
... H 10 O 2 S 2 ... Form: White crystalline powder Assay: greater ... By IR Melting Point: greater than ... less than or equal to 1% ...
... consists of an anodized aluminum body in ... Compounds embedded in polymerized matrix. It is ... and Synergy Multi-Detection Readers. This multi-functional test ... reducing the need for tedious wet testing. ...
Biology Products: